Good MorningEquity markets tried to rebound on Wednesday but stumbled after getting what they wanted: soft labor data. While the ADP and JOLTs figures suggest softening in the labor market and may lead the FOMC to cut rates sooner than expected, there is a downside that should be considered. Slowing labor market growth and business spending will impact GDP in 2024 and may lead the economy into recession. The odds of a soft landing have grown in recent months, but investors should not be sanguine, the Fed has been behind the curve since the beginning of the inflation crisis and is unlikely to proactively cut rates. Cutting too soon will result in accelerating inflation and higher rates for longer.
The S&P 500 continues hovering at critical resistance with several potential catalysts. The first comes on Friday with the NFP report, expected to show a solid job gain of 190,000, the next is the following week and includes a double-shot of inflation news, the FOMC decisions and retail sales. The CPI and PPI will most likely confirm slowing inflation but the retail sales may also confirm weak spending and lackluster holiday season. Featured: Trump’s treachery (Ad) 
|
Stocks | | |
If you're like most shoppers, you order many of the items you use daily online. In recent years, online shopping has evolved and adapted to people's needs, and very successful companies work exclusively online to address the specific needs of their consumers.
Savvy investors have noticed this tre... Read the Full Story |
|
From Our PartnersREVEALED: $194 Trillion Trump Market Pattern
Trump fires off a tweet and stocks tank…
He gives a speech and the markets soar…
Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets.
And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance. | | | Click here to discover this exciting new trading pattern. |
|
Stocks | | |
Looking for consumer staples dividend stocks?
When investors are uncertain, they often look to consumer staples stocks since these companies sell things we can't go without, such as food, beverages and household products.
When inflation is high, investing in consumer staples stocks with di... Read the Full Story |
|
Markets | | | Large, well-established, and financially stable businesses with a long history of reliable performance are often referred to as blue-chip companies. These companies are typically leaders in their industries and tend to have strong market positions, large market capitalizations, and robust financials... Read the Full Story |
|
|
Markets | | |
When many investors first begin building an investment portfolio, they inadvertently veer toward the consumer staples sector. Consumer staples are companies that produce and sell essential products that people use daily, regardless of economic conditions. These companies tend to represent more sta... Read the Full Story |
|
Markets | | | Wall Street rose Thursday to snap its first three-day losing streak since Halloween.The S&P 500 climbed 36.25 points, or 0.8%, to 4,585.59. The Dow Jones Industrial Average added 62.95, or 0.2%, to 36,117.38, and the Nasdaq composite jumped 193.28, or 1.4%, to 14,339.99.Big Tech stocks helped po... Read the Full Story |
|
From Our PartnersBehind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented.
And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots…
What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book. | | | Claim your FREE copy of Crypto Revolution now. |
|
Markets | | |
When investing for dividends, a vital sequence is the ex dividend date vs record date. To be entitled to a company's dividend payout, an investor must hold shares through a specific day, which will vary depending on the company. Investors with long time horizons using "buy and hold" strategies don... Read the Full Story |
|
Markets | | | The heads of Wall Street’s biggest banks used an appearance on Capitol Hill to plead with senators to stop the Biden administration’s proposed changes to how banks are regulated, warning that the proposals could negatively impact the economy at a time of geopolitical turmoil and inflation Read the Full Story |
|
Markets | | | Federal regulators are investigating ExxonMobil's $60 billion deal to acquire a Texas oil company in what would be one the largest mergers in the energy industry in two decades, according to securities filings.The Federal Trade Commission, which enforces federal antitrust law, has asked for addition... Read the Full Story |
|
Markets | | | A lawyer for JetBlue Airways said Tuesday that the biggest U.S. airlines are using their size to cement their dominance in a post-pandemic world, making it critical that a federal judge allow JetBlue to buy Spirit Airlines.The lawyer, Ryan Shores, said JetBlue needs Spirit to be a “viable challenger... Read the Full Story |
|
Markets | | | Credit rating agency Moody’s cut its outlook for Chinese sovereign bonds to negative on Tuesday, citing risks from a slowing economy and a crisis in its property sector. Moody’s said the downgrade, its first for China since 2017, reflects risks from financing troubles of local and regional governmen... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts. | | View Today's Stock Pick |
|
